2nd_Computerized Asthma Specific Quality of Life(cAQOL)
2nd_Computerized Asthma Specific Quality of Life(cAQOL)
Comparison of the responsiveness of two different asthma-specific QOL measures (AQLQ and
 cAQOL) in Korean patients with persistent asthma
Inclusion Criteria:

 -  Patient aged 20-70 years

 -  Patient diagnosed with asthma over six months ago

 -  Asthma diagnosis

 -  Airway reversibility, FEV1 ≥ 12% and 200mL or

 -  Airway hyper-responsiveness, PC20 < 16 mg/mL or

 -  More than two weeks, more than 2 times a day in excess of 20% PEFR diurnal
 variability patient

 -  FEV1 55-100% of predicted value patient

 -  Inhaled corticosteroids alone or inhaled corticosteroids and beta agonists used
 patient

 -  Currently, at least if you have one or more asthma symptoms, asthma control test (ACT
 • Asthma Control Test) score of less than 19 characters

 -  Patients who sufficiently listen to the purpose and content of this trial and the
 properties of investigational products and voluntarily agree with the participation to
 sign a written consent approved by IRB of Ajou University Medical Center before the
 participation in this trial

 Exclusion Criteria:

 -  Current smoking or smoking in the past 15packyears

 -  Patients who show a symptom of an acute disease within 14 days before the beginning of
 this trial (administration of trial medication)

 -  Recent changes in asthma treatment for 28days

 -  Chronic diseases that affect the quality of life